MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN. (Q38913478)

7 September 2017

MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN. (English)

1 reference

7 September 2017

hepatocellular carcinoma

1 reference

Shi-Yan Yan

1

1 reference

7 September 2017

Mei-Mei Chen

2

1 reference

7 September 2017

Guang-Ming Li

3

1 reference

7 September 2017

Yu-Qin Wang

4

1 reference

7 September 2017

Jian-Gao Fan

5

1 reference

7 September 2017

3 February 2015

1 reference

7 September 2017

1 reference

7 September 2017

36

1 reference

7 September 2017

6

1 reference

7 September 2017

4747-4755

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3124-9

7 September 2017

0 references

cites work

Sorafenib in liver cancer--just the beginning

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNAs accurately identify cancer tissue origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

microRNA-32 inhibits the proliferation and invasion of the SGC-7901 gastric cancer cell line in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

Downregulated microRNA-32 expression induced by high glucose inhibits cell cycle progression via PTEN upregulation and Akt inactivation in bone marrow-derived mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNA-203 inhibits cell proliferation by repressing ΔNp63 expression in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3124-9

Molecular pathogenesis of human hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Cytotoxicity of voriconazole on cultured human corneal endothelial cells

1 reference

12 December 2020

MicroRNA-146a inhibits glioma development by targeting Notch1

1 reference

12 December 2020

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

1 reference

12 December 2020

miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition

1 reference

12 December 2020

10.1007/S13277-015-3124-9

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference